Engage with PROCEPT BioRobotics at the Upcoming Investor Event
PROCEPT BioRobotics Corporation (NASDAQ: PRCT), a notable entity in the surgical robotics space, is eager to connect with investors during an in-person event. This gathering is set to occur at the esteemed American Urological Association Annual Meeting, located in a vibrant venue known for fostering significant discussions in the field.
Details of the Investor Event
The investor event will unfold on a Friday, providing an opportunity for attendees to interact with the management team directly. It will take place in the illustrious Venetian Hotel, known for its luxurious settings and inspiring atmosphere. Scheduled for 8:00 AM to 9:30 AM Pacific Time, the event promises to be enlightening.
Meet the Management Team
During the session, key figures from PROCEPT BioRobotics will share insights and developments regarding the company's innovations. The management team includes:
- Reza Zadno – Chief Executive Officer
- Kevin Waters – Chief Financial Officer
- Sham Shiblaq – Chief Commercial Officer
- Barry Templin – Chief Technology Officer
Clinical Insights from Renowned Physicians
This investor event is complemented by invaluable clinical perspectives from distinguished urologists. Noteworthy speakers include:
- Dr. Inderbir Gill, a prominent leader in urology, noted for his role at USC Urology.
- Dr. Brian Helfand, Division Chief of Urology at Endeavor Health, bringing a wealth of expertise in cancer surgery.
- Dr. Gerald Park, a notable partner at Kansas City Urology Care, sharing vital insights in the field.
The Value of the Live Webcast
For those unable to attend in person, PROCEPT BioRobotics will provide a live webcast. This ensures that the important topics discussed will reach a wider audience. Following the event, the archived recording will be accessible on the company’s website within the 'Investors' section, allowing interested stakeholders to view it for at least 90 days after the event.
Upcoming Financial Reports
Further to the investor engagement, the company will announce its financial results for the first quarter soon. This report will be released before the market opens and will be followed by a conference call hosted by the management team. Investors will have a chance to listen to the discussions and clarifications regarding the numbers and company strategy going forward.
Exploring PROCEPT BioRobotics
PROCEPT BioRobotics excels in developing innovative solutions tailored to enhance urological care. The company proudly manufactures the AQUABEAM and HYDROS Robotic Systems, which utilize advanced technology to provide therapies that are effective, safe, and sustainable. Their Aquablation therapy stands out for its independence from factors traditionally affecting treatment outcomes, like prostate size or the surgeon's experience.
The Need for Innovative Solutions
Given that BPH (Benign Prostatic Hyperplasia) significantly impacts about 40 million men in the U.S., the demand for effective treatment options continues to grow. PROCEPT BioRobotics, through its commitment to clinical research, has amassed over 150 peer-reviewed publications. This impressive body of work underlines the effectiveness and clinical advantages of Aquablation therapy.
Conclusion
This investor event marks a significant occasion for PROCEPT BioRobotics and its stakeholders. With a skilled leadership team and innovative technology designed to address an expansive patient need, the company is well-positioned for future growth.
Frequently Asked Questions
What is the focus of PROCEPT BioRobotics Corporation?
PROCEPT BioRobotics focuses on advancing patient care through innovative surgical robotics solutions, particularly within urology.
When is the investor event scheduled to take place?
The investor event will be held on April 25, 2025, from 8:00 AM to 9:30 AM Pacific Time.
Who from the management team will be present at the event?
Key members such as the CEO and CFO will be present to engage with investors and share insights.
Is there a webcast available for those unable to attend?
Yes, a live webcast will be available, and an archived recording can be accessed for 90 days post-event.
What does Aquablation therapy aim to achieve?
Aquablation therapy aims to provide effective, safe, and durable treatment outcomes for men experiencing LUTS due to BPH.
